Form DRS - Draft Registration Statement:
SEC Accession No. 0001640334-17-002570
Filing Date
2017-12-01
Accepted
2017-11-30 21:41:05
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1041353
2 filename2.htm EX-3.1 5236
3 filename3.htm EX-3.2 45996
4 filename4.htm EX-10.2 91928
5 filename5.htm EX-10.3 96769
6 filename6.htm EX-21.1 1480
7 filename7.htm EX-23.2 1376
8 inmune_ex31img19.jpg GRAPHIC 137626
9 inmune_ex31img20.jpg GRAPHIC 63586
10 inmune_ex31img21.jpg GRAPHIC 106566
11 inmune_ex31img22.jpg GRAPHIC 79940
12 inmune_ex31img23.jpg GRAPHIC 114053
13 inmune_ex31img24.jpg GRAPHIC 92560
14 inmune_ex31img25.jpg GRAPHIC 180025
15 inmune_ex31img26.jpg GRAPHIC 164794
16 inmune_ex31img27.jpg GRAPHIC 121386
17 inmune_ex106img1.jpg GRAPHIC 12514
  Complete submission text file 0001640334-17-002570.txt   2764048
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01812 | Film No.: 171232585
SIC: 2836 Biological Products, (No Diagnostic Substances)